Development of a Novel, High-Level Protein Expression Platfrom Based on Plant Nectar
The ability to produce high levels of therapeutic proteins at low costs could result in improved health care for large numbers of individuals. NERP seeks to create a new biopharmaceutical protein production platform that will have significant advantages by lowering the costs of production and of purification for therapeutic proteins. NERP is considering two potential therapeutic protein targets for expression, interferon-b1a and erythropoietin.
Small Business Information at Submission:
NERP Technologies, Inc.
807 Hodge Avenue Ames, IA 50010
Number of Employees: